On September 10, 2020 Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, reported James Caruso, president and CEO, will present at the following investor conferences in September and be available for 1×1 meetings (Press release, Cellectar Biosciences, SEP 10, 2020, View Source [SID1234569924]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 22nd Annual Global Investment Conference
Date: Tuesday, September 15, 2020
Time: 3:30 pm Eastern Time
Format: Virtual Presentation and 1×1 meetings

Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Date: Monday, September 21, 2020
Time: 4:10 pm Eastern Time
Format: Virtual Presentation and 1×1 meetings

A replay of the presentation and webcast will be on the Investor Relations section of the company’s website available for 90 days here.